Nalaganje...

Preclinical Evaluation of (203/212)Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer

Targeted radiopharmaceutical therapy (TRT) using α-particle radiation is a promising approach for treating both large and micrometastatic lesions. We developed prostate-specific membrane antigen (PSMA)–targeted low-molecular-weight agents for (212)Pb-based TRT of patients with prostate cancer (PC) b...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Nucl Med
Main Authors: Banerjee, Sangeeta Ray, Minn, Il, Kumar, Vivek, Josefsson, Anders, Lisok, Ala, Brummet, Mary, Chen, Jian, Kiess, Ana P., Baidoo, Kwamena, Brayton, Cory, Mease, Ronnie C., Brechbiel, Martin, Sgouros, George, Hobbs, Robert F., Pomper, Martin G.
Format: Artigo
Jezik:Inglês
Izdano: Society of Nuclear Medicine 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954458/
https://ncbi.nlm.nih.gov/pubmed/31253744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.229393
Oznake: Označite
Brez oznak, prvi označite!